最終更新日:2022/12/24
The ICS formulations reported in the trials included beclometasone, budesonide, ciclesonide, flunisolide, fluticasone, and mometasone.
編集履歴(0)
The ICS formulations reported in the trials included beclometasone, budesonide, ciclesonide, flunisolide, fluticasone, and mometasone.